| scholarly article | Q13442814 |
| P50 | author | Inna G Ovsyannikova | Q88569357 |
| Gregory A. Poland | Q22096751 | ||
| Robert M. Jacobson | Q38639354 | ||
| Robert Vierkant | Q42681243 | ||
| P2093 | author name string | Neelam Dhiman | |
| P2860 | cites work | New methods for assessing T-cell responses | Q34076691 |
| Selective in vivo suppression of T lymphocyte responses in experimental measles virus infection | Q35678720 | ||
| Cytokine secretion patterns and cross-regulation of T cell subsets | Q36440960 | ||
| Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody | Q36520317 | ||
| Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons | Q36736379 | ||
| Enzyme-linked immunosorbent assay for detection of measles antibody | Q37306741 | ||
| Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children | Q37388113 | ||
| Duration of live measles vaccine-induced immunity | Q37907461 | ||
| Measles, mumps, and rubella vaccines | Q38146816 | ||
| Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus | Q40217832 | ||
| Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses. | Q40221648 | ||
| A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles | Q40886277 | ||
| Single cell analyses of cytokine production | Q41429688 | ||
| Viral induction of low frequency interferon-alpha producing cells | Q41436973 | ||
| IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. | Q43615014 | ||
| Secondary failure rates of measles vaccines: a metaanalysis of published studies | Q44757631 | ||
| Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones | Q45010858 | ||
| Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response | Q45772830 | ||
| Role of virus strain dm conventional and enhanced measles plaque neutralization test | Q45791537 | ||
| Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal | Q46725441 | ||
| Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells. | Q52965153 | ||
| Cellular Immunity in Measles Vaccine Failure: Demonstration of Measles Antigen-Specific Lymphoproliferative Responses despite Limited Serum Antibody Production after Revaccination | Q54156984 | ||
| Measles antibody seroprevalence rates among immunized Inuit, Innu and Caucasian subjects1 | Q57158077 | ||
| Fatal Measles Pneumonia Without Rash in a Child with AIDS | Q64130099 | ||
| Immune activation during measles: interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease | Q67276345 | ||
| Immunity against measles and rubella in Massachusetts schoolchildren | Q68958747 | ||
| Antibody response following measles-mumps-rubella vaccine under conditions of customary use | Q71834226 | ||
| Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination | Q73318528 | ||
| Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins | Q73378147 | ||
| Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines | Q73482280 | ||
| Disturbances in gamma globulin synthesis as experiments of nature | Q74107472 | ||
| Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months | Q74442119 | ||
| Attenuated Measles Vaccine in Children with Acute Leukemia | Q79022270 | ||
| P433 | issue | 3 | |
| P921 | main subject | measles | Q79793 |
| vaccine | Q134808 | ||
| P304 | page(s) | 411-416 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine | |
| P478 | volume | 10 |
| Q81918606 | A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes |
| Q36999524 | Attenuated measles virus as a vaccine vector |
| Q26700080 | Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination |
| Q45422417 | Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination |
| Q45355448 | Cytokines expression profile and kinetics of Peste des petits ruminants virus antigen and antibody in infected and vaccinated goats |
| Q43097342 | Development of an artificial-antigen-presenting-cell-based assay for the detection of low-frequency virus-specific CD8(+) T cells in whole blood, with application for measles virus |
| Q42219928 | ELISA for detection of humoral immunity against measles. |
| Q58055167 | Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART |
| Q36312960 | Emerging diseases: measles |
| Q41557807 | Evaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350. |
| Q39726079 | Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouse |
| Q34579842 | Global measles elimination |
| Q45511303 | HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine |
| Q51071320 | HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. |
| Q42422163 | HLA-DR specific monoclonal antibodies block lymphoproliferative response to measles vaccine in vitro: a pilot study |
| Q35869228 | Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose |
| Q92881586 | Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises |
| Q84078925 | Humoral and cellular immune responses to measles and tetanus: the importance of elapsed time since last exposure and the nature of the antigen |
| Q38036063 | Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions |
| Q42242910 | Immunogenicity of a recombinant measles HIV-1 subtype C vaccine |
| Q34505337 | Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine |
| Q35754384 | Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides |
| Q45487514 | Induction of CD4 T cell proliferation and in vitro Th1-like cytokine responses to measles virus |
| Q45787560 | Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses |
| Q42850418 | Influence of HLA-DRB1 alleles on lymphoproliferative responses to a naturally processed and presented measles virus phosphoprotein in measles immunized individuals |
| Q48079491 | Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003. |
| Q44581629 | Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic |
| Q44417125 | Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005. |
| Q57072744 | New Vaccine Technologies to Combat Outbreak Situations |
| Q40059020 | Novel viral vectors in infectious diseases |
| Q27484362 | Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus |
| Q34129876 | Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses |
| Q51830138 | Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference. |
| Q45415561 | Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus. |
| Q34629595 | Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge |
| Q45386726 | Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses |
| Q35941639 | The regulation and maturation of antiviral immune responses |
| Q36390054 | Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques |
Search more.